We are studying whether the FDA approved vaccine, BexseroTM, which is already proven to provide protection against Meningitis B, will also provide protection against the bacteria that causes gonorrhea. Researchers at UNC-Chapel Hill have been working for over two decades to develop preventative measures for a common STD, Gonorrhea. Currently, antibiotics are available that are highly effective for curing Gonorrhea, but antibiotic resistance in the bacteria that causes Gonorrhea is on the rise and no vaccine has been proven in a clinical trial to protect individuals from Gonorrhea.
You will be asked to receive 3 FDA-approved vaccinations and a controlled challenge with bacteria to test protection. At most visits you will be asked to provide a urine sample. In addition, a few of the visits will require a blood draw.
up to $1100 , Monetary reimbursement for extensive travel to research site (based on mileage) and receipt of 3 FDA-approved vaccines free of charge
Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
UNC Global Clinical Research North (GCRN)
1828 MLK Jr Blvd, Chapel Hill, NC 27514, USA
Institute for Global Health and Infectious Diseases
Clinical or Medical
Healthy Volunteer or General Population
Sexual and/or Reproductive Health
Wellness and Lifestyle
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.